Yong Hong Xiao

Summary

Country: China

Publications

  1. pmc Changes in chinese policies to promote the rational use of antibiotics
    Yonghong Xiao
    Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
    PLoS Med 10:e1001556. 2013
  2. doi request reprint The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China
    Yonghong Xiao
    State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    Microb Drug Resist 18:42-6. 2012
  3. doi request reprint Epidemiology and characteristics of antimicrobial resistance in China
    Yong Hong Xiao
    State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China
    Drug Resist Updat 14:236-50. 2011
  4. ncbi request reprint [A multi-center, randomized, controlled, double blind and double dummy clinical trial of antofloxacin hydrochloride tablet versus levofloxacin tablet for the treatment of acute bacterial infections]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100191, China
    Zhonghua Nei Ke Za Zhi 50:225-9. 2011
  5. ncbi request reprint Pharmacokinetics of metadoxine for injection after repeated doses in healthy volunteers
    Yuan Lu
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100083, China
    Chin Med J (Engl) 120:166-8. 2007
  6. ncbi request reprint [Clinical and laboratory problems related to the application of antibiotics]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Peking University, Beijing 100083, China
    Zhonghua Yi Xue Za Zhi 83:357-9. 2003
  7. ncbi request reprint Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers
    Yuan Lu
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100191, China
    Chin Med J (Engl) 124:242-5. 2011
  8. ncbi request reprint [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Peking University, Beijing 100038 China
    Zhonghua Yi Xue Za Zhi 84:1867-71. 2004
  9. ncbi request reprint [Concept of pharmacokinetics/pharmacodynamics in Antibiotics and its clinical significance]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Beijing University, Beijing 100083, China
    Zhonghua Yi Xue Za Zhi 84:1914-5. 2004
  10. ncbi request reprint [Study on drug resistance and molecular epidemiology of Streptococcus pneumoniae isolated in Chongqing]
    Cheng Yao
    Department of Infectious Diseases, The First Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing 400016, China
    Zhonghua Liu Xing Bing Xue Za Zhi 26:431-4. 2005

Detail Information

Publications10

  1. pmc Changes in chinese policies to promote the rational use of antibiotics
    Yonghong Xiao
    Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
    PLoS Med 10:e1001556. 2013
    ..Please see later in the article for the Editors' Summary. ..
  2. doi request reprint The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China
    Yonghong Xiao
    State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    Microb Drug Resist 18:42-6. 2012
    ..The dominant type of aminoglycoside-modifying enzyme, AAC(3)-II, might be the main source of the disparity in E. coli resistance to different aminoglycoside agents...
  3. doi request reprint Epidemiology and characteristics of antimicrobial resistance in China
    Yong Hong Xiao
    State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China
    Drug Resist Updat 14:236-50. 2011
    ..aeruginosa and extensive-resistant A. baumannii, and the antimicrobial resistance in primary healthcare and outpatient setting should be intensely monitored and investigated in the future...
  4. ncbi request reprint [A multi-center, randomized, controlled, double blind and double dummy clinical trial of antofloxacin hydrochloride tablet versus levofloxacin tablet for the treatment of acute bacterial infections]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100191, China
    Zhonghua Nei Ke Za Zhi 50:225-9. 2011
    ..To evaluate the clinical efficacy and safety of antofloxacin hydrochloride tablet for the treatment of acute bacterial infections...
  5. ncbi request reprint Pharmacokinetics of metadoxine for injection after repeated doses in healthy volunteers
    Yuan Lu
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100083, China
    Chin Med J (Engl) 120:166-8. 2007
  6. ncbi request reprint [Clinical and laboratory problems related to the application of antibiotics]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Peking University, Beijing 100083, China
    Zhonghua Yi Xue Za Zhi 83:357-9. 2003
  7. ncbi request reprint Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers
    Yuan Lu
    Institute of Clinical Pharmacology, First Hospital, Peking University, Beijing 100191, China
    Chin Med J (Engl) 124:242-5. 2011
    ..The purpose of the study was to evaluate the pharmacokinetic characteristics of single and multiple oral doses of antofloxacin hydrochloride in Chinese healthy male volunteers...
  8. ncbi request reprint [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Peking University, Beijing 100038 China
    Zhonghua Yi Xue Za Zhi 84:1867-71. 2004
    ..To compare the pharmacokinetics/pharmacodynamics property of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections and evaluate the recommended regimens...
  9. ncbi request reprint [Concept of pharmacokinetics/pharmacodynamics in Antibiotics and its clinical significance]
    Yong Hong Xiao
    Institute of Clinical Pharmacology, Beijing University, Beijing 100083, China
    Zhonghua Yi Xue Za Zhi 84:1914-5. 2004
  10. ncbi request reprint [Study on drug resistance and molecular epidemiology of Streptococcus pneumoniae isolated in Chongqing]
    Cheng Yao
    Department of Infectious Diseases, The First Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing 400016, China
    Zhonghua Liu Xing Bing Xue Za Zhi 26:431-4. 2005
    ..To investigate the prevalence and drug resistance of Streptococcus (S.) pneumoniae in patients infected in communities and molecular epidemiology with BOX-polymerase chain reaction (PCR) in Chongqing areas...